Simple Summary Multiple myeloma is a cancer of plasma cells, which secrete an abnormal antibody. The class of that antibody is identified in every patient during routine diagnostic work-up at no additional cost, but it plays no part in the scores used to assess disease aggressiveness. We reviewed 196 patients who recei...
Tuba Güllü Koca, Nizameddin Koca, F. Hunutlu et al.· Cancers· 0 citations
A low pre-treatment CALLY index was associated with shorter progression-free survival in early-stage cHL; this hypothesis-generating finding requires external and positron-emission-tomography-adapted validation.
Tuba Güllü Koca, Nizameddin Koca, F. Hunutlu et al.· Uludağ Üniversitesi Tıp Fakü...· 0 citations
Background/aim Chronic lymphocytic leukemia (CLL) exhibits marked biological heterogeneity, and immunoglobulin heavy chain variable (IgHV) mutation status remains a key prognostic biomarker. We evaluated patient IgHV status via RNA sequencing (RNA-seq) and examined real-life clinical outcomes in a retrospective CLL coh...
F. Arıkan, P. Ata, Şenol Demir et al.· Turkish Journal of Medical S...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.